Tectonic Therapeutic (TECX) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
8 Jun, 2026Opening remarks and agenda
Meeting commenced at 9:00 A.M. on June 8, 2026, with polls opened for voting on all matters.
The meeting was held virtually and recorded for future reference.
Board members, executive officers, and the independent auditor were introduced.
The agenda included three proposals: election of directors, auditor ratification, and executive compensation.
Board and executive committee updates
Board members and executive officers present included François Nader, Praveen Tipirneni, Stefan Vitorovic, Tim Springer, Phil Dannenberg, Jessica Chutter, Dan Lochner, Marcella Ruddy, Peter McNamara, and Marc Schwabish.
Shareholder proposals
Three proposals were presented: election of two Class II directors, ratification of Deloitte & Touche LLP as auditor, and advisory vote on executive compensation.
Latest events from Tectonic Therapeutic
- Net loss widened to $22.3M in Q2 2026 as R&D spending rose; cash reserves at $227.1M.TECX
Q2 2026 - Advancing GPCR-targeted biologics for PH and HHT with strong clinical progress and market potential.TECX
Investor presentation - TX45 demonstrated robust efficacy and safety in PH-HFpEF, targeting a large unmet need.TECX
TD Cowen 45th Annual Healthcare Conference - TX45 and TX2100 advance as differentiated GPCR biologics for high-value, underserved markets.TECX
Investor presentation - Q1 2026 net loss rose to $25.2M as R&D spending increased; cash runway extends into Q4 2028.TECX
Q1 2026 - Virtual annual meeting to vote on directors, auditor, and executive pay, with board support.TECX
Proxy filing - Director elections, auditor ratification, and executive pay are key items at the 2026 virtual meeting.TECX
Proxy filing - TX45 and TX2100 advance in the clinic, with differentiated strategies and strong preclinical data.TECX
Leerink Global Healthcare Conference 2026 - Advancing novel therapies for pulmonary hypertension and HHT, with pivotal data expected by 2027.TECX
TD Cowen 46th Annual Health Care Conference